ACHC analyst estimates
Acadia Healthcare (ACHC) analyst ratings, the average price target and its range, and every firm's latest call.
ACHC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 28, 2026 | Raymond James | Raymond James Assumes Acadia Healthcare (ACHC) at Outperform | $39.00 |
| Sep 23, 2026 | Leerink Partners | Acadia Healthcare price target raised to $33 from $30 at Leerink | $33.00 |
| Jul 30, 2026 | Barclays | Acadia Healthcare price target raised to $32 from $25 at Barclays | $32.00 |
| Jul 30, 2026 | Guggenheim | Acadia Healthcare price target raised to $39 from $38 at Guggenheim | $39.00 |
| Jul 20, 2026 | Guggenheim | Acadia Healthcare price target raised to $38 from $31 at Guggenheim | $38.00 |
| Jul 14, 2026 | KeyBanc | Acadia Healthcare price target raised to $40 from $30 at KeyBanc | $40.00 |
| Jul 9, 2026 | UBS | Acadia Healthcare price target raised to $39 from $31 at UBS | $39.00 |
| Jun 3, 2026 | Jefferies | Jefferies Upgrades Acadia Healthcare (ACHC) to Buy | $30.00 |
| May 27, 2026 | KeyBanc | KeyBanc Reiterates Overweight Rating on Acadia Healthcare (ACHC) | $30.00 |
| May 4, 2026 | Guggenheim | Acadia Healthcare price target raised to $31 from $26 at Guggenheim | $31.00 |
| May 4, 2026 | RBC Capital | Acadia Healthcare price target raised to $31 from $28 at RBC Capital | $31.00 |
| May 1, 2026 | Cantor Fitzgerald | Acadia Healthcare price target raised to $30 from $20 at Cantor Fitzgerald | $30.00 |
| Apr 30, 2026 | Barclays | Acadia Healthcare price target raised to $25 from $20 at Barclays | $25.00 |
| Apr 20, 2026 | Jefferies | Acadia Healthcare price target raised to $24.50 from $20 at Jefferies | $24.50 |
| Apr 17, 2026 | UBS | Acadia Healthcare price target raised to $31 from $27 at UBS | $31.00 |
- 12 firms rate ACHC: 7 buy, 4 hold, 1 sell.
- The average price target is $35.38 from 8 analysts, from $30.00 to $40.00.
Updated 2026-11-02 23:10 UTC